相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations
Alice S. Mims et al.
LEUKEMIA (2021)
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
Christine H. Chung et al.
CANCERS (2021)
Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
Yangyang She et al.
CANCER CELL INTERNATIONAL (2020)
In silico analysis of the immune microenvironment in bladder cancer
Ye Zhang et al.
BMC CANCER (2020)
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
Maria Giuseppa Vitale et al.
CLINICAL GENITOURINARY CANCER (2020)
Neoantigens in Hematologic Malignancies
Melinda A. Biernacki et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer immunotherapy comes of age and looks for maturity
Amanda Finck et al.
NATURE COMMUNICATIONS (2020)
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically
Krzysztof Mrozek et al.
LEUKEMIA (2019)
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
Cristina Toffalori et al.
NATURE MEDICINE (2019)
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
Maximilian Stahl et al.
CURRENT ONCOLOGY REPORTS (2019)
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
Maddalena Noviello et al.
NATURE COMMUNICATIONS (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA)
Cun-Te Chen et al.
JOURNAL OF CANCER (2019)
Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword
Willemijn Hobo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
A. Stengel et al.
LEUKEMIA (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
A-K Eisfeld et al.
LEUKEMIA (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Natural killer cell-mediated immunosurveillance of human cancer
Karl-Johan Malmberg et al.
SEMINARS IN IMMUNOLOGY (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome
Maja D. Andersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
Klaus H. Metzeler et al.
BLOOD (2016)
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes
Tapan M. Kadia et al.
CANCER (2016)
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S. Davids et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Emerging roles of p53 and other tumour-suppressor genes in immune regulation
Cesar Munoz-Fontela et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
Chi Young Ok et al.
LEUKEMIA RESEARCH (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis
Philipp A. Dietrich et al.
BLOOD (2014)
Molecular regulation of effector and memory T cell differentiation
John T. Chang et al.
NATURE IMMUNOLOGY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
Lisa M. Kopp et al.
MOLECULAR IMMUNOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Differential niche and Wnt requirements during acute myeloid leukemia progression
Steven W. Lane et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Impact of the hypomethylating agent 5-azacytidine on dendritic cells function
Jihane Frikeche et al.
EXPERIMENTAL HEMATOLOGY (2011)
Demethylating treatment suppresses natural killer cell cytolytic activity
Xiao-ning Gao et al.
MOLECULAR IMMUNOLOGY (2009)
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis
D. Bowen et al.
LEUKEMIA (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Post-translational modification of p53 in tumorigenesis
AM Bode et al.
NATURE REVIEWS CANCER (2004)
Mast cells: the JEKYLL and HYDE of tumor growth
TC Theoharides et al.
TRENDS IN IMMUNOLOGY (2004)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
分享论文
